Grennan, Matthew
Email Address
ORCID
Disciplines
Search Results
Now showing 1 - 2 of 2
Publication The FDA and the Regulation of Medical Device Innovation: A Problem of Information, Risk, and Access(2016-02-01) Grennan, Matthew; Town, Robert JAre FDA premarket trials on new drugs and medical devices excessive and do they inhibit consumer access to new and much-needed technologies? Or may they actually be insufficient and expose consumers to too much risk? To address this question, the new research described here compares the regulatory approaches of the U.S. and the European Union for second and third generation coronary stents. The research supports the FDA’s argument that reductions in their standards for device approval would reduce consumer welfare. Nevertheless, the research also suggests that in some circumstances, FDA reform proposals advocating for more relaxed premarket requirements but enhanced post-market surveillance would yield considerable welfare gains.Publication Transparency and Negotiated Prices: The Value of Information in Hospital-Supplier Bargaining(2016-03-21) Grennan, Matthew; Swanson, AshleyHospitals that join a pricing database are able to reduce the negotiated prices they pay to medical technology companies. Reductions are concentrated among hospitals previously paying high prices relative to other hospitals and for products purchased in relatively large volumes. Transparency may offer significant savings on medical devices.